Mitochondrial Atpif1 regulates haem synthesis in developing erythroblasts

Area of Science:

• Mitochondrial biology
• Hematology
• Biochemistry

Background:

• Defects in heme synthesis cause congenital anemias.
• The role of mitochondrial homeostasis regulators in heme synthesis is unclear.

Purpose of the Study:

• To investigate the function of mitochondrial ATPase inhibitory factor 1 (Atpif1) in heme biosynthesis.
• To elucidate the mechanism by which Atpif1 regulates ferrochelatase (Fech) activity.

Main Methods:

• Zebrafish genetic screens to identify novel regulators of heme synthesis.
• Cloning of Atpif1 from an anemic zebrafish mutant.
• Genetic complementation studies using Fech constructs.
• Pharmacological modulation of mitochondrial pH and redox potential.

Main Results:

• Atpif1 directly regulates the catalytic efficiency of vertebrate Fech.
• Loss of Atpif1 impairs hemoglobin synthesis in zebrafish, mouse, and human models.
• Atpif1 deficiency leads to diminished Fech activity and elevated mitochondrial pH.
• The [2Fe-2S] cluster in Fech makes it sensitive to Atpif1-regulated mitochondrial perturbations.

Conclusions:

• Atpif1 is a key regulator of mitochondrial heme homeostasis and red blood cell development.
• Atpif1 deficiency causes anemia by reducing Fech efficiency.
• Atpif1 dysfunction may contribute to human diseases like congenital sideroblastic anemias and mitochondriopathies.